Results
Emmessar Biotech Q2 FY26 Net Profit at ₹14.03 Lakh
Emmessar Biotech submitted audited Q2 FY26 results to BSE with ₹14.03 lakh net profit and ₹62.50 lakh revenue.
Company operates healthcare and land leasing segments, with rent contributing ₹41.33 lakh
